A social science framework for the analysis of health technology regulation: the risks and benefits of innovative pharmaceuticals in a comparative context

Author： Abraham John  

Publisher： Routledge Ltd

ISSN： 1469-8331

Source： Health, Risk & Society, Vol.4, Iss.3, 2002-11, pp. : 305-324

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Trading risks for markets: the international harmonisation of pharmaceuticals regulation

By Abraham John   Reed Tim  

Health, Risk & Society, Vol. 3, Iss. 1, 2001-03 ,pp. : 113-128

Routledge Ltd

Access to resources Recommend Favorite

The Translational Science Benefits Model: A New Framework for Assessing the Health and Societal Benefits of Clinical and Translational Sciences

By  

CLINICAL AND TRANSLATIONAL SCIENCE (ELECTRONIC), Vol. 11, Iss. 1, 2018-01 ,pp. : 77-84

John Wiley & Sons Inc

Access to resources Recommend Favorite

Assessing environmental health risks or net health benefits?

By Tuomisto Jouni   Pekkanen Juha  

Scandinavian Journal of Public Health, Vol. 33, Iss. 3, 2005-06 ,pp. : 162-163

Informa Healthcare

Access to resources Recommend Favorite

Addressing the health technology assessment of biosimilar pharmaceuticals

By Stewart Alan   Aubrey Philip   Belsey Jonathan  

Current Medical Research and Opinion, Vol. 26, Iss. 9, 2010-09 ,pp. : 2119-2126

Informa Healthcare

Access to resources Recommend Favorite

HEALTH TECHNOLOGY ASSESSMENT IN EVALUATION OF PHARMACEUTICALS IN THE CZECH REPUBLIC

By  

International Journal of Technology Assessment in Health Care, Vol. 33, Iss. 3, 2017-04 ,pp. : 339-344

Cambridge University Press

Access to resources Recommend Favorite